SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kyoung Jee Seo, Yang Won Nah, Chang Woo Nam, Sang Jun Park, Hong Rae Cho, Optimal Level of Tacrolimus to Minimize Nephrotoxicity in Liver Transplantation, The Journal of the Korean Society for Transplantation, 2014, 28, 1, 13

    CrossRef

  2. 2
    Lewis Teperman, Dilip Moonka, Anthony Sebastian, Linda Sher, Paul Marotta, Christopher Marsh, Baburao Koneru, John Goss, Dennis Preston, John P. Roberts, Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial, Liver Transplantation, 2013, 19, 7
  3. 3
    Susanne Beckebaum, Vito R. Cicinnati, Arnold Radtke, Iyad Kabar, Calcineurin inhibitors in liver transplantation – still champions or threatened by serious competitors?, Liver International, 2013, 33, 5
  4. 4
    James F. Trotter, Monica Grafals, Angel E. Alsina, Early use of renal-sparing agents in liver transplantation: A closer look, Liver Transplantation, 2013, 19, 8
  5. 5
    Maria-Carlota Londoño, Antoni Rimola, John O’Grady, Alberto Sanchez-Fueyo, Immunosuppression minimization vs. complete drug withdrawal in liver transplantation, Journal of Hepatology, 2013, 59, 4, 872

    CrossRef

  6. 6
    Jacek Klepacki, Jelena Klawitter, Jamie Bendrick-Peart, Bjorn Schniedewind, Svenja Heischmann, Touraj Shokati, Uwe Christians, Jost Klawitter, A high-throughput U-HPLC–MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine, Journal of Chromatography B, 2012, 883-884, 113

    CrossRef

  7. 7
    L. Fischer, J. Klempnauer, S. Beckebaum, H. J. Metselaar, P. Neuhaus, P. Schemmer, U. Settmacher, N. Heyne, P-A. Clavien, F. Muehlbacher, I. Morard, H. Wolters, W. Vogel, T. Becker, M. Sterneck, F. Lehner, C. Klein, G. Kazemier, A. Pascher, J. Schmidt, F. Rauchfuss, A. Schnitzbauer, S. Nadalin, M. Hack, S. Ladenburger, H. J. Schlitt, A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT, American Journal of Transplantation, 2012, 12, 7
  8. 8
    A. D. Goralczyk, N. Bari, W. Abu-Ajaj, T. Lorf, G. Ramadori, T. Friede, A. Obed, Calcineurin Inhibitor Sparing With Mycophenolate Mofetil in Liver Transplantion: A Systematic Review of Randomized Controlled Trials, American Journal of Transplantation, 2012, 12, 10
  9. 9
    Belinda Martínez-Saldivar, Jhon Prieto, Marina Berenguer, Manuel de la Mata, José-Antonio Pons, Trinidad Serrano, Lourdes Rafael-Valdivia, Victoria Aguilera, Pilar Barrera, Pascual Parrilla, Sara Lorente, Angel Rubin, Enrique Fraga, Antoni Rimola, Control of Blood Pressure in Liver Transplant Recipients, Transplantation Journal, 2012, 93, 10, 1031

    CrossRef

  10. 10
    Ali Zarrinpar, Ronald W Busuttil, Immunomodulating options for liver transplant patients, Expert Review of Clinical Immunology, 2012, 8, 6, 565

    CrossRef

  11. 11
    Susumu Shibasaki, Kenichiro Yamashita, Ryoichi Goto, Tetsu Oura, Kenji Wakayama, Gentaro Hirokata, Tomohiro Shibata, Rumi Igarashi, Sanae Haga, Michitaka Ozaki, Satoru Todo, NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats, Transplant Immunology, 2012, 26, 1, 42

    CrossRef

  12. 12
    Fuat H. Saner, Vito R. Cicinnati, Georgios Sotiropoulos, Susanne Beckebaum, Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation, Liver International, 2012, 32, 2
  13. 13
    Y.-H. Lin, C.-C. Lin, C.-C. Wang, S.-H. Wang, Y.-W. Liu, C.-C. Yong, T.-L. Lin, W.-F. Li, A.M. Concejero, C.-L. Chen, The 4-Week Serum Creatinine Level Predicts Long-Term Renal Dysfunction After Adult Living Donor Liver Transplantation, Transplantation Proceedings, 2012, 44, 3, 772

    CrossRef

  14. 14
    Ranjeeta Bahirwani, Oren Shaked, Shanu Kurd, Roy Bloom, K. Rajender Reddy, Chronic Kidney Disease After Orthotopic Liver Transplantation: Impact of Hepatitis C Infection, Transplantation, 2011, 91, 11, 1245

    CrossRef

  15. 15
    Susanne Beckebaum, Vito R. Cicinnati, Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?, Digestive Diseases and Sciences, 2011, 56, 1, 4

    CrossRef

  16. 16
    Thomas Gerhardt, Uwe Pöge, Birgit Stoffel-Wagner, Holger Palmedo, Tilman Sauerbruch, Rainer Peter Woitas, Creatinine-based glomerular filtration rate estimation in patients with liver disease, European Journal of Gastroenterology & Hepatology, 2011, 23, 11, 969

    CrossRef

  17. 17
    Kentaro Ide, Yuka Tanaka, Takashi Onoe, Masataka Banshodani, Hirofumi Tazawa, Yuka Igarashi, Nabin Bahadur Basnet, Marlen Doskali, Hirotaka Tashiro, Hideki Ohdan, Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function, Journal of Transplantation, 2011, 2011, 1

    CrossRef

  18. 18
    C. Duvoux, G.P. Pageaux, Immunosuppression in liver transplant recipients with renal impairment, Journal of Hepatology, 2011, 54, 5, 1041

    CrossRef

  19. 19
    Armin D. Goralczyk, Nicola Hauke, Narin Bari, Tung Y. Tsui, Thomas Lorf, Aiman Obed, Interleukin 2 receptor antagonists for liver transplant recipients: A systematic review and meta-analysis of controlled studies, Hepatology, 2011, 54, 2
  20. 20
    Toshiyasu Kawahara, Sonal Asthana, Norman M. Kneteman, m-TOR inhibitors: What role in liver transplantation?, Journal of Hepatology, 2011, 55, 6, 1441

    CrossRef

  21. 21
    Michael Kriss, Eva U. Sotil, Michael Abecassis, Mary Welti, Josh Levitsky, Mycophenolate mofetil monotherapy in liver transplant recipients, Clinical Transplantation, 2011, 25, 6
  22. 22
    Y.B. Chen, S.D. Li, B.L. Ju, X.J. Shi, F. Lu, D.K. Hu, C.H. Yu, J.H. Dong, Suitable Calcineurin Inhibitor Concentrations for Liver Transplant Recipients in the Chinese Population, Transplantation Proceedings, 2011, 43, 5, 1751

    CrossRef

  23. 23
    Paige Porrett, Abraham Shaked, The failure of immunosuppression withdrawal: Patient benefit is not detectable, inducible, or reproducible, Liver Transplantation, 2011, 17, S3
  24. 24
    Samuel Haywood, Michael Abecassis, Josh Levitsky, The renal benefit of mycophenolate mofetil after liver transplantation, Clinical Transplantation, 2011, 25, 1
  25. You have free access to this content25
    Maria Siemionow, Aleksandra Klimczak, Advances in the development of experimental composite tissue transplantation models, Transplant International, 2010, 23, 1
  26. 26
    David Guillén, Federico Cofán, Emilio Ros, Olga Millán, Montse Cofán, Mercè Brunet, Biomarker Assessment of the Immunomodulator Effect of Atorvastatin in Stable Renal Transplant Recipients and Hypercholesterolemic Patients, Molecular Diagnosis & Therapy, 2010, 14, 6, 357

    CrossRef

  27. 27
    M. B. Greenblatt, A. Aliprantis, B. Hu, L. H. Glimcher, Calcineurin regulates innate antifungal immunity in neutrophils, Journal of Experimental Medicine, 2010, 207, 5, 923

    CrossRef

  28. 28
    G. Herlenius, M. Felldin, G. Nordén, M. Olausson, L. Bäckman, B. Gustafsson, S. Friman, Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial, Transplantation Proceedings, 2010, 42, 10, 4441

    CrossRef

  29. 29
    Michael L. Bentley, Howard L. Corwin, Joseph Dasta, Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies, Critical Care Medicine, 2010, 38, S169

    CrossRef

  30. 30
    Giuseppe Orlando, Finding the right time for weaning off immunosuppression in solid organ transplant recipients, Expert Review of Clinical Immunology, 2010, 6, 6, 879

    CrossRef

  31. 31
    Edith Koehler, Kymberly Watt, Michael Charlton, Fatty Liver and Liver Transplantation, Clinics in Liver Disease, 2009, 13, 4, 621

    CrossRef

  32. 32
    C. Duvoux, D. Samuel, La transplantation hépatique, Gastroentérologie Clinique et Biologique, 2009, 33, 8-9, 868

    CrossRef

  33. 33
    Svetlana Karie-Guigues, Nicolas Janus, Faouzi Saliba, Jerome Dumortier, Christophe Duvoux, Yvon Calmus, Richard Lorho, Gilbert Deray, Vincent Launay-Vacher, Georges-Philippe Pageaux, Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study, Liver Transplantation, 2009, 15, 9
  34. 34
    Ranjeeta Bahirwani, K. Rajender Reddy, Outcomes after liver transplantation: Chronic kidney disease, Liver Transplantation, 2009, 15, S2
  35. 35
    Michael R. Charlton, William J. Wall, Akinlolu O. Ojo, Pere Ginés, Stephen Textor, Fuad S. Shihab, Paul Marotta, Marcelo Cantarovich, James D. Eason, Russell H. Wiesner, Michael A. Ramsay, Juan C. Garcia-Valdecasas, James M. Neuberger, Sandy Feng, Connie L. Davis, Thomas A. Gonwa, Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation, Liver Transplantation, 2009, 15, 11
  36. 36
    Luit Penninga, Andre Wettergren, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients, The Cochrane Library,
  37. 37
    Luit Penninga, Andre Wettergren, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Calcineurin inhibitor reduction or withdrawal versus continuation of calcineurin inhibitor treatment for liver transplant recipients, The Cochrane Library,
  38. 38
    Luit Penninga, Andre Wettergren, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipients, The Cochrane Library,
  39. 39
    Samir Parekh, James R. Spivey, Recurrent Disease after Liver Transplantation,